Product NDC: | 17478-050 |
Proprietary Name: | Sufenta |
Non Proprietary Name: | sufentanil citrate |
Active Ingredient(s): | 50 ug/mL & nbsp; sufentanil citrate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17478-050 |
Labeler Name: | Akorn |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019050 |
Marketing Category: | NDA |
Start Marketing Date: | 20101201 |
Package NDC: | 17478-050-01 |
Package Description: | 10 AMPULE in 1 CARTON (17478-050-01) > 1 mL in 1 AMPULE |
NDC Code | 17478-050-01 |
Proprietary Name | Sufenta |
Package Description | 10 AMPULE in 1 CARTON (17478-050-01) > 1 mL in 1 AMPULE |
Product NDC | 17478-050 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sufentanil citrate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20101201 |
Marketing Category Name | NDA |
Labeler Name | Akorn |
Substance Name | SUFENTANIL CITRATE |
Strength Number | 50 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |